AT 101,  Bcl-2 and Mcl-1 inhibitor (BH3-mimetic) (ab145624)

Overview

  • Product name

    AT 101,  Bcl-2 and Mcl-1 inhibitor (BH3-mimetic)
  • Description

    Pro-apoptotic agent. BH3-mimetic. Bcl-2 and Mcl-1 inhibitor.
  • Biological description

    Pro-apoptotic agent. BH3-mimetic. Bcl-2 and Mcl-1 inhibitor. Gossypol (ab141050, ab144391) enantiomer. Induces Noxa and PUMA. Shows antiproliferative and chemosensitizing effects in vivo. Orally active.
  • Purity

    > 98%
  • CAS Number

    90141-22-3
  • Chemical structure

    Chemical Structure

Properties

  • Chemical name

    (R)-1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-[2,2'-binaphthalene]-8,8'-dicarboxaldehyde
  • Molecular weight

    518.56
  • Molecular formula

    C30H30O8
  • Storage instructions

    Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
  • Solubility overview

    Soluble in ethanol to 75 mM and in DMSO to 75 mM
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILES

    OC1=C(O)C(C(C)C)=C(C=C(C)C(C2=C(O)C(C(C([H])=O)=C(O)C(O)=C3C(C)C)=C3C=C2C)=C4O)C4=C1C([H])=O
  • Source

    Synthetic

  • Research areas

References

This product has been referenced in:

  • Kaza N  et al. BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. PLoS One 9:e96733 (2014). Read more (PubMed: 24824755) »
  • Ren T  et al. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway. Drug Des Devel Ther 8:2517-29 (2014). Read more (PubMed: 25548514) »
  • Imai A  et al. Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects. Cancer Res 72:716-25 (2012). Read more (PubMed: 22158856) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab145624.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up